Segui
Alessandro Romanel
Alessandro Romanel
Department of Cellular, Computational and Integrative (CIBIO), University of Trento, Italy
Email verificata su unitn.it - Home page
Titolo
Citata da
Citata da
Anno
Punctuated Evolution of Prostate Cancer Genomes
SC Baca, D Prandi, MS Lawrence, JM Mosquera, A Romanel, Y Drier, ...
Cell 153 (3), 666-677, 2013
14652013
A highly specific SpCas9 variant is identified by in vivo screening in yeast
A Casini, M Olivieri, G Petris, C Montagna, G Reginato, G Maule, ...
Nature biotechnology 36 (3), 265-271, 2018
5322018
Plasma AR and abiraterone-resistant prostate cancer
A Romanel, DG Tandefelt, V Conteduca, A Jayaram, N Casiraghi, ...
Science Translational Medicine 7 (312), 312re10-312re10, 2015
4702015
Tumor clone dynamics in lethal prostate cancer
S Carreira, A Romanel, J Goodall, E Grist, R Ferraldeschi, S Miranda, ...
Science Translational Medicine 6 (254), 254ra125-254ra125, 2014
3982014
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response
H Beltran, K Eng, JM Mosquera, A Sigaras, A Romanel, H Rennert, ...
JAMA Oncology, 2015
3142015
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution …
V Conteduca, D Wetterskog, MTA Sharabiani, E Grande, ...
Annals of Oncology, mdx155, 2017
2802017
A phase II trial of the aurora kinase A inhibitor alisertib for patients with castration resistant and neuroendocrine prostate cancer: efficacy and biomarkers
H Beltran, C Oromendia, DC Danila, B Montgomery, C Hoimes, ...
Clinical Cancer Research, clincanres. 1912.2018, 2018
2412018
Comprehensive analysis of genetic ancestry and its molecular correlates in cancer
J Carrot-Zhang, N Chambwe, JS Damrauer, TA Knijnenburg, ...
Cancer Cell 37 (5), 639-654. e6, 2020
2212020
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer
H Beltran, A Romanel, V Conteduca, N Casiraghi, M Sigouros, ...
The Journal of Clinical Investigation 130 (4), 2020
1672020
Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations
FW Huang, JM Mosquera, A Garofalo, C Oh, M Baco, A Amin-Mansour, ...
Cancer discovery 7 (9), 973-983, 2017
1262017
The BlenX language: a tutorial
L Dematté, C Priami, A Romanel
Lecture Notes in Computer Science 5016, 313-365, 2008
1132008
Unraveling the clonal hierarchy of somatic genomic aberrations
D Prandi, SC Baca, A Romanel, CE Barbieri, JM Mosquera, J Fontugne, ...
Genome biology 15, 1-16, 2014
1112014
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit
G Petris, A Casini, C Montagna, F Lorenzin, D Prandi, A Romanel, ...
Nature Communications 8, 2017
1072017
The Beta Workbench: a computational tool to study the dynamics of biological systems
L Dematté, C Priami, A Romanel
Briefings in bioinformatics 9 (5), 437-449, 2008
1052008
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care
H Rennert, K Eng, T Zhang, A Tan, J Xiang, A Romanel, R Kim, W Tam, ...
NPJ genomic medicine 1 (1), 1-11, 2016
852016
Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer
G Schaefer, JM Mosquera, R Ramoner, K Park, A Romanel, E Steiner, ...
Prostate cancer and prostatic diseases 16 (2), 132-138, 2013
852013
ASEQ: fast allele-specific studies from next-generation sequencing data
A Romanel, S Lago, D Prandi, A Sboner, F Demichelis
BMC medical genomics 8 (1), 9, 2015
732015
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC
S La Monica, R Minari, D Cretella, L Flammini, C Fumarola, M Bonelli, ...
Journal of Experimental & Clinical Cancer Research 38 (1), 222, 2019
542019
RB1 Heterogeneity in Advanced Metastatic Castration Resistant Prostate Cancer
DN Rodrigues, N Casiraghi, A Romanel, M Crespo, S Miranda, ...
Clinical Cancer Research, clincanres. 2068.2018, 2018
54*2018
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
D Liu, JE Shoag, D Poliak, RS Goueli, V Ravikumar, D Redmond, ...
Nature communications 11 (1), 1987, 2020
512020
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20